Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Keel Infrastructure Corp. Common Stock (KEEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Keel Infrastructure Corp. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Keel Infrastructure Corp. Common Stock trades at $3.04 (market cap $1.93B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 6.5× Keel Infrastructure Corp. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Keel Infrastructure Corp. Common Stock for 1 Days on average.
| HALO | KEEL | |
|---|---|---|
Market Cap | $12.58B | $1.93B |
Volume | 2,179,278 | 30,868,523 |
Sector | Health | Technology |
52-Week High | $115.22 | $6.66 |
52-Week Low | $61.63 | $1.71 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $2.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →
